Portfolio News

CORRECTING and REPLACING Neuraly Announces First Patient Dosed in Phase 2 Clinical Trial of NLY01 for Patients with Parkinson’s Disease

All mentions of NLY01 have been corrected -- Neuraly, a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced the dosing of the first patient in its Phase 2 clinical trial of NLY01 for Parkinson’s disease. Read more >>
Read more...

PlaceMe opens the first official co-living building in MA

PlaceMe, Boston’s pioneer co-living company, is launching the first official co-living building in Cambridge, MA. Starting April 1, 2020, the three-story building will accommodate 26 residents, offering all the benefits of the shared living concept: no-hassle moving, fully furnished units, a prime location at accessible rents which include utilities, wifi, and cleaning of shared areas, as well as dedicated community events.Read more >>
Read more...

Myomo® Signs Nationwide Payer Network Agreement with HOMELINK

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with HOMELINK which will enable Myomo to process out-of-network claims for its MyoPro powered orthosis with the 1,200 payers in HOMELINK’s network. Read more >>
Read more...

Visually-impaired student receives eSight

A visually impaired Richmond Senior High School student has received eSight glasses, the same high-tech glasses that Michael Clinton received in December, thanks to support from the Richmond County community and a grant from the Knights of the Blind. Read more >>
Read more...